Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
This St Nick Truly Can Advise How To Drink And Hack Your Headache - 2Air travelers face higher ticket prices as Iran war drives up oil prices
- 3Book excerpt: "Enough" by Dr. Ania Jastreboff and Oprah Winfrey
- 4Golan resident convicted of spying for Iran after passing tank movement, missile-impact data
- 5Creative Do-It-Yourself Ventures for Each Expertise Level
- Living Abroad: Social Inundation and Self-improvement
- James Webb Space Telescope finds strongest evidence yet for atmosphere around rocky exoplanet: 'It's really like a wet lava ball'
- This professional Santa's dream of spreading holiday cheer fuels stroke recovery
- Well known SUVs With Low Energy Utilization In 2024 vote
- 4 Family SUVs: Joining Solace and Style
- Hezbollah claims right to respond to killing of top commander
- The EU Is Considering Lifting Tariffs on Chinese Electric Vehicles
- Financial plan Cordial Home Redesigns That Add Worth
- 4 African Vacationer Locations
